glp-1 obesity drug news today oct 2025 Market obesity drug news today glp-1

Additional Resources Diabetes Therapy: Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study Webinar on Health Plan Executive Survey on GLP-1 Cost Crisis About Virta Health Virta Health is redefining the standard of care for metabolic diseases such as obesity, type 2 diabetes, and prediabetes

Their therapeutic potential is evident in various disease contexts, including type 2 diabetes, neurodegenerative disorders, and inflammatory bowel disease (IBD)

Blind&mdash%%%Loop&mdash%%%Syndrome (change in the course of the intestine after gastric surgery)

They, you know, collected data from, like, over 600,000 veterans